trending Market Intelligence /marketintelligence/en/news-insights/trending/us3hmmG75xYhVtP53xW9Bw2 content esgSubNav
In This List

Quadrivio & Pambianco-managed fund to inject capital into Rougj

Blog

Banking Essentials Newsletter: July Edition - Part 2

Blog

Anticipate the Unknown Go Beyond Fundamentals to Uncover Early Signs of Private Company Credit Deterioration

Blog

Taking Loss Given Default Estimation to the Next Level: An Aspiration for All Creditors, Not Just Banks

Blog

Anticipate the Unknown A Fundamentals Approach to Detect Early Signs of Private Company Credit Deterioration


Quadrivio & Pambianco-managed fund to inject capital into Rougj

A Quadrivio & Pambianco-managed private equity fund agreed to invest in Rougj, formally known as Laboratorio alla Borsa Srl.

The target company is focused on the formulation, production and distribution of cosmetic products in the pharmacy sector.

The investment will be made through The Made in Italy Fund through a combination of acquisition of shares and capital infusion. The company will use the investment in part to enter into strategic markets such as Germany, the U.K. and China.

Entrepreneurs Antonio Pirillo, Marco Giraldi and Alessandro Fier will continue to own a significant share in the business. Ettore Favia, who led the company in its latest development phase, will depart the company.

Legance and DLA Piper provided legal assistance to Quadrivio & Pambianco and Rougj, respectively. EY conducted accounting and tax due diligence.